Commonwealth Equity Services, LLC Neuro Sense Therapeutics Ltd. Transaction History

Commonwealth Equity Services, LLC

  • $77.2 Billion
  • Q3 2025

A detailed history of Commonwealth Equity Services, LLC transactions in Neuro Sense Therapeutics Ltd. stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 21,080 shares of NRSN stock, worth $20,658. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,080
Previous 21,080 -0.0%
Holding current value
$20,658
Previous $40,000 35.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 06, 2025
BUY
$0.91 - $2.49 $3,485 - $9,536
3,830 Added 22.2%
21,080 $40,000
Q1 2025

May 09, 2025
BUY
$0.93 - $1.21 $930 - $1,210
1,000 Added 6.15%
17,250 $16,000
Q4 2024

Feb 10, 2025
BUY
$0.86 - $1.36 $3,117 - $4,930
3,625 Added 28.71%
16,250 $20,000
Q3 2024

Oct 18, 2024
BUY
$0.63 - $1.35 $7,953 - $17,043
12,625 New
12,625 $16,000

Others Institutions Holding NRSN

# of Institutions
11
Shares Held
278K
Call Options Held
0
Put Options Held
0
View Full List

About NeuroSense Therapeutics Ltd.

NRSN Quotes by TradingView
  • Ticker NRSN
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,674,000
  • Market Cap $11.4M
More about NRSN
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email